Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Tweddle

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Oncogene|May 30, 2007
Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival dataM Łastowska, V Viprey, M Santibanez-Koref, et al.
Journal of Clinical Pathology|August 7, 2008
Histological profile of tumours from MYCN transgenic miceH C Moore, K M Wood, M S Jackson, et al.
British Journal of Cancer|October 28, 2010
Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699R A Daniel, A L Rozanska, E A Mulligan, et al.
British Journal of Cancer|October 31, 2014
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplificationR Defferrari, K Mazzocco, I M Ambros, et al.
British Journal of Cancer|December 8, 2011
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)G Schleiermacher, J Michon, A Ribeiro, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Oncogene|May 30, 2007
Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival dataM Łastowska, V Viprey, M Santibanez-Koref, et al.
Journal of Clinical Pathology|August 7, 2008
Histological profile of tumours from MYCN transgenic miceH C Moore, K M Wood, M S Jackson, et al.
British Journal of Cancer|October 28, 2010
Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699R A Daniel, A L Rozanska, E A Mulligan, et al.
British Journal of Cancer|October 31, 2014
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplificationR Defferrari, K Mazzocco, I M Ambros, et al.
British Journal of Cancer|December 8, 2011
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)G Schleiermacher, J Michon, A Ribeiro, et al.
Pageof 2